11/14/2024
11:24 AM | CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/28/2024
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
10/28/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 424B3 | |
10/21/2024
3:16 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
3:20 PM | Galmed Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
10/15/2024
3:15 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:05 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/20/2024
3:46 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
1:17 PM | Galmed Pharmaceuticals (Subject)
Otsuka Masaya (Filed by)
| Form SC 13G | |
09/20/2024
1:18 PM | Galmed Pharmaceuticals (Subject)
Otsuka Masaya (Filed by)
| Form SC 13G/A | |
09/19/2024
6:13 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
09/09/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 424B3 | |
08/30/2024
3:25 PM | Galmed Pharmaceuticals (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/28/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:15 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
7:50 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
3:16 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2024
3:30 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
3:54 PM | Galmed Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/15/2024
8:13 AM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:52 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/29/2023
11:15 PM | Galmed Pharmaceuticals (Filer)
| Form EFFECT | |
11/22/2023
3:48 PM | Galmed Pharmaceuticals (Filer)
| Form POS AM | |
11/20/2023
3:37 PM | Galmed Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
